Available and future treatments for erectile dysfunction

Clinical Cornerstone

Volumn 7, Issue 1, 2005, Pages 37-44

  Dinsmore, Wallace W ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIEMETIC AGENT; APOMORPHINE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; MELANOCORTIN RECEPTOR; NITRIC ACID DERIVATIVE; NITRIC OXIDE DONOR; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; POTASSIUM CHANNEL STIMULATING AGENT; PROSTAGLANDIN E1; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; VARDENAFIL; VASOACTIVE INTESTINAL POLYPEPTIDE; YOHIMBINE; PHOSPHODIESTERASE INHIBITOR;

ACNE; ANORGASMIA; ANXIETY DISORDER; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; DYSPEPSIA; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FACE DISORDER; FLUSHING; GENE THERAPY; GYNECOMASTIA; HEADACHE; HUMAN; HYPOTENSION; INJECTION PAIN; LIVER DISEASE; MEDICAL DECISION MAKING; NAUSEA; NONHUMAN; NOSE CONGESTION; PAIN; PATIENT COUNSELING; PENILE FIBROSIS; PENIS DISEASE; PENIS PROSTHESIS; PRIAPISM; PROSTATE DISEASE; PUMP; RHINITIS; SEXUAL DYSFUNCTION; SEXUALITY; SIDE EFFECT; SKIN BRUISING; SKIN DISEASE; SKIN IRRITATION; SLEEP APNEA SYNDROME; SOMNOLENCE; SURGICAL TECHNIQUE; SWEATING; SYNCOPE; TACHYCARDIA; TREATMENT PLANNING; URETHRAL BLEEDING; URETHRAL PAIN; URINARY FREQUENCY; VACUUM; VIRAL GENE DELIVERY SYSTEM; YAWNING; IMPOTENCE; MALE; PATHOPHYSIOLOGY; REVIEW;

APOMORPHINE; HUMANS; IMPOTENCE; MALE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITORS; TESTOSTERONE; YOHIMBINE;

EID: 27744542228     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(05)80047-X     Document Type: Article

References (23)

1. Padma-Nathan H Hellstrom WJ Kaiser FE Labasky RF Lue TF Nolten WE et al. N Engl J Med 336 1997 1-7
2. Wespes E Amar E Hatzichristou D Montorsi F Pryor J Vardi Y Guidelines on erectile dysfunction Eur Urol 41 2002 1-5
3. Levine SB Erectile dysfunction: Why drug therapy isn't always enough Cleve Clin J Med 70 2003 241-246
4. Erectile Dysfunction Alliance UK Management guidelines for erectile dysfunction 1999 The Royal Society of Medicine Press London
5. Gresser U Gleiter CH Erectile dysfunction: Comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil-review of the literature Eur J Med Res 7 2002 435-446
6. Fazio L Brock G Erectile dysfunction: Management update CMAJ 170 2004 1429-1437
7. Dula E Keating W Siami PF Edmonds A O'neil J Buttler S Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group Urology 56 2000 130-135
8. Padma-Nathan H Fromm-Freeck S Ruff DD McMurray JG Rosen RC Apomorphine SL study group Efficacy and safety of apomorphine SL vs. placebo for male erectile dysfunction (MED) [abstract] J Urol 159 Suppl 241 1998
9. Mulhall JP Sublingual apomorphine for the treatment of erectile dysfunction Expert Opin Investig Drugs 11 2002 295-302
10. Tam SW Worcel M Wyllie M Yohimbine: A clinical review Pharmacol Ther 91 2001 215-243
11. Goldstein I Carson C Rosen R Islam A Vasomax for the treatment of male erectile dysfunction World J Urol 19 2001 51-56
12. Ugarte F Hurtado-Coll A Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction Int J Impot Res 14 Suppl 2 2002 S48-S53
13. Becher E Topical alprostadil cream for the treatment of erectile dysfunction Expert Opin Pharmacother 5 2004 623-632
14. Jain P Rademaker AW McVary KT Testosterone supplementation for erectile dysfunction: Results of a meta-analysis J Urol 164 2000 371-375
15. Dinsmore WW Gingell C Hackett G Kell P Savage D Oakes R et al. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel autoinjector system: A multicentre double-blind placebo-controlled study BJU Int 83 1999 274-279
16. Fitkin J Ho GT Peyronie's disease: Current management Am Fam Physician 60 1999 549-552
17. Goldstein J Newman L Baum N Brooks M Chaikin L Goldberg K et al. Safety and efficacy outcome of mentor alpha-1 inflatable penile prosthesis implantation for impotence treatment J Urol 157 1997 833-839
18. Steers WD Viability and safety of combination drug therapies for erectile dysfunction J Urol 170 2003 S20-S23 discussion S23
19. Andersson KE Hedlund P New directions for erectile dysfunction therapies Int J Impot Res 14 Suppl 1 2002 S82-S92
20. Ruiz Rubio JL Hernandez M Rivera de los Arcos L Benedito S Recio P Garcia P et al. Role of ATP-sensitive K+ channels in relaxation of penile resistance arteries Urology 63 2004 800-805
21. Vick RN Benevides M Patel M Parivar K Linnet O Carson CC The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction J Urol 167 2002 2618-2623
22. Bivalacqua TJ Champion HC Abdel-Mageed AB Kadowitz PJ Hellstrom WJ Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat Biol Reprod 65 2001 1371-1377
23. Truss MC Becker AJ Thon WF Kuczyk M Djamilian MH Stief CG et al. Intracavernous calcitonin gene-related peptide plus prostaglandin E1: possible alternative to penile implants in selected patients Eur Urol 26 1994 40-45